The Spanish Biotech Sector - presentation at BioAsia 2013
-
Upload
bioasia-the-global-bio-business-forum -
Category
Business
-
view
304 -
download
1
description
Transcript of The Spanish Biotech Sector - presentation at BioAsia 2013
(07/02/2013)1
UNIÓN EUROPEA
Fondo Europeo deDesarrollo Regional (FEDER)
Una manera de hacer Europa
The Spanish Biotech sector in figures
Juan Carlos Cortés
International DirectorCentre for the Development of Industrial Technology
Ministry of Economy & Competitiveness
(07/02/2013)2
UNIÓN EUROPEA
Fondo Europeo deDesarrollo Regional (FEDER)
Una manera de hacer Europa
• A young sector, 15 years old.• Internationalization is part of its DNA.• Success depends on the capacity to export.• Crucial: joint projects and technology exchange
agreements.
The Spanish Biotech sector
Spain:• Biotech industry growth in the last four years 350%• A key player in R&D, spin-offs, research and
collaboration.• Biotech: a key sector in the knowledge economy
3 (07/02/2013)
UNIÓN EUROPEA
Fondo Europeo deDesarrollo Regional (FEDER)
Una manera de hacer Europa
• Nº enterprises: 1.715 (617 EB+1.098 EIB)
• Nº personnel employed EB1+EIB2: 163.526
• Estimated turnover EB (2010): 60.122 MM€
• Internal expenditures in R&D: 568.280 M€ (11,2% increase from
2009)
• Enterprises related to human health: 67%
• Enterprises related to agro-food: 23%
• Enterprises related to industrial processing: 10%
Source: Genoma España/ASEBIOSource: Genoma España/ASEBIO
2EIB: industrial commercial or services’ enterprise, with interests, develpments and products in
biotechnology
1EB: biotechology enterprise
The Spanish Biotech sector now
4 (07/02/2013)
UNIÓN EUROPEA
Fondo Europeo deDesarrollo Regional (FEDER)
Una manera de hacer Europa
Contribution of Biotechnology tothe Spanish economy
Contribution toGDP 2010 (%)
1,2
Contribution toGDP 2010 (%)
1,2OECD predictionGDP 2030 (%)
2,7
OECD predictionGDP 2030 (%)
2,7
GDP Contribution
Employment
Macroeconomic impact of biotechnology
Contribution to GDP (%)
Predicted contribution to GDP (%)
Employment
Predicted employment
5 (07/02/2013)
UNIÓN EUROPEA
Fondo Europeo deDesarrollo Regional (FEDER)
Una manera de hacer Europa
Agriculture
Classification of Bio-companies
Food
Environment
Animal Health
Human Health
6 (07/02/2013)
UNIÓN EUROPEA
Fondo Europeo deDesarrollo Regional (FEDER)
Una manera de hacer Europa
Profile of the Biotechnology enterprise (EB) in Spain
• Between 10 and 20 employees
• Over 80% of the staff university graduates
• Over 25% of the staff devoted to R&D
• Less than 5 years of activity
• Located mostly in Madrid, Barcelona, Andalucía, País Vasco and Valencia
• Linked to prestigious public research institutions
7 (07/02/2013)
UNIÓN EUROPEA
Fondo Europeo deDesarrollo Regional (FEDER)
Una manera de hacer Europa
Spain : eight Bioregions
8 (07/02/2013)
UNIÓN EUROPEA
Fondo Europeo deDesarrollo Regional (FEDER)
Una manera de hacer Europa
The Spanish Biotech sector : scientific production (00-08)
Growth: 47% (annual rate 6%)
Source: Genoma EspañaSource: Genoma España
European contribution to world scientific production in biosciences (2000)
European contribution to world scientific production in biosciences (2008)
United Kingdom
Germany
France
Italy
Netherlands
Spain
Sweden
Belgium
Denmark
Finland
Austria
Greece
Portugal
Ireland
Luxembourg
Germany
United Kingdom
France
Italy
Spain
Netherlands
Sweden
Denmark
Belgium
Austria
Finland
Greece
Ireland
Portugal
Luxembourg
9 (07/02/2013)
UNIÓN EUROPEA
Fondo Europeo deDesarrollo Regional (FEDER)
Una manera de hacer Europa
The Biotech sector in Spain : evolution of the nº of enterprises (00-08)
Source: Genoma EspañaSource: Genoma España
Evolution of EB and EIB
10 (07/02/2013)
UNIÓN EUROPEA
Fondo Europeo deDesarrollo Regional (FEDER)
Una manera de hacer Europa
The biotech sector in Spain : total public expenditures on R&D&I biotech
Source: Genoma EspañaSource: Genoma España
Total public support for R&D&I in Biotechnology (Mio €)
11 (07/02/2013)
UNIÓN EUROPEA
Fondo Europeo deDesarrollo Regional (FEDER)
Una manera de hacer Europa
Success stories
- 2000: Pfizer invested 12m euros in its European Biometric Centre, which has support functions for the rest of Europe and USA.- 2002: Abengoa signed a 35.5million dollar R&D Agreement with the US Department of Energy.- 2002: Lilly opened its research centre for medicinal chemistry, one of the biggest in the world, investing 20 million euros.- 2003: Serono concentrates its global growth-hormone production in Spain.- 2005: GSK opens its research centre for tropical diseases in Spain.- 2009: Genzyme sets up a sales office in Madrid and has a warehouse for domestic distribution.- 2011: Celgene opens its first research centre outside the USA in Seville. The Celgene Institute of Translational Research Europe (CITRE) plans to focus on advanced therapies and regenerative medicine.
12 (07/02/2013)
UNIÓN EUROPEA
Fondo Europeo deDesarrollo Regional (FEDER)
Una manera de hacer Europa
Spanish Technology Platforms
• Biotech Markets• Nanomedicine www.nanomedspain.net/• Innovative Medicines www.medicamentos-
innovadores.org/• Plants Biotechnology www.invigen.org• Animal Health www.vetmasi.es
13 (07/02/2013)
UNIÓN EUROPEA
Fondo Europeo deDesarrollo Regional (FEDER)
Una manera de hacer Europa
CDTI DATA 2011
RTD Project and NEOTEC
Nr .of fundedcompanies
CDTI funding Total investment
92 M€48,116 M€ 64,6
INNPRONTA call
Nr. of fundedcompanies
CDTI funding Total investment
(2 Projects) 17 M€ 27,67 M€ 32,56
Indo-Spanishcall CDTI-DBT
Nr. of proposals Selectedprojects
First call 2012 7 3
14 (07/02/2013)
UNIÓN EUROPEA
Fondo Europeo deDesarrollo Regional (FEDER)
Una manera de hacer Europa
Potential areas for cooperationSPANISH TECHNOLOGICAL STRENGTHS
Health and Nano biotechnology
Some Developments in 2011 • Oncology,: Advancell, GP Pharm, Ingenasa, Pharmamar, IUCT, Lipopharma, Entrechem,
Orizon Genomics
• Cardiology/ Neurological: Neuron Pharma, Sanifit,
• Oftalmology: Sylentis, Proretina Therapeutics, Biotechnology Institute, Bioftalmic
• Vaccines: Archivel Farma, Ferrer, Rovi, Leti
• Biotech diagnosis, biomarkers, nanomedicine: Orizon Genomics, Sistemas Genomicos, AB
BIOTICs, Genomica, Biobide, Pangaea Biotech, Genetadi Botech, Aromics, Nanotherapy,
Nanoinmunotech…
• Animal Health: Bionaturis, Ingenasa
• Bioinformatic: Integromics, Noray Bio, Biomol Informatics
• Regenerative medicine, Cell and Gene therapy: Tigenics (former Cellerix)
• Biofuels: Abengoa, Repsol
4th Nano biotechnology Scientific production in the world • Barcelona the 2nd Nano biotech city (1st Boston)
15 (07/02/2013)
UNIÓN EUROPEA
Fondo Europeo deDesarrollo Regional (FEDER)
Una manera de hacer Europa
www.asebio.com
• ASEBIO is the Spanish Asociation of Biocompanies
• ASEBIO belongs to and is supported by EUROPABIO, and is a part of CEOE and SEBBM
Institutions supporting the sector in Spain:
Promoting value creation through knowledge